Hearing loss in children receiving cisplatin chemotherapy - PubMed (original) (raw)
Hearing loss in children receiving cisplatin chemotherapy
V A McHaney et al. J Pediatr. 1983 Feb.
No abstract available
Similar articles
- Ototoxicity with cisplatin therapy.
Mahoney DH Jr, Weaver T, Steuber CP, Starling KA. Mahoney DH Jr, et al. J Pediatr. 1983 Dec;103(6):1006-7. doi: 10.1016/s0022-3476(83)80747-1. J Pediatr. 1983. PMID: 6685758 No abstract available. - Progressive hearing loss after completion of cisplatin chemotherapy is common and more pronounced in children without spontaneous otoacoustic emissions before chemotherapy.
Weissenstein A, Deuster D, Knief A, Zehnhoff-Dinnesen AA, Schmidt CM. Weissenstein A, et al. Int J Pediatr Otorhinolaryngol. 2012 Jan;76(1):131-6. doi: 10.1016/j.ijporl.2011.10.020. Epub 2011 Nov 21. Int J Pediatr Otorhinolaryngol. 2012. PMID: 22104469 - The importance of high-tone audiometry in monitoring for ototoxicity.
Tange RA, Dreschler WA, van der Hulst RJ. Tange RA, et al. Arch Otorhinolaryngol. 1985;242(1):77-81. doi: 10.1007/BF00464411. Arch Otorhinolaryngol. 1985. PMID: 3899068 - Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers.
Lee JW, Pussegoda K, Rassekh SR, Monzon JG, Liu G, Hwang S, Bhavsar AP, Pritchard S, Ross CJ, Amstutz U, Carleton BC; CPNDS Clinical Recommendations Group. Lee JW, et al. Ther Drug Monit. 2016 Aug;38(4):423-31. doi: 10.1097/FTD.0000000000000298. Ther Drug Monit. 2016. PMID: 26960170 Review. - Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW, van den Berg H, van Dalen EC. van As JW, et al. Cochrane Database Syst Rev. 2012 May 16;(5):CD009219. doi: 10.1002/14651858.CD009219.pub2. Cochrane Database Syst Rev. 2012. PMID: 22592737 Updated. Review.
Cited by
- Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
van As JW, van den Berg H, van Dalen EC. van As JW, et al. Cochrane Database Syst Rev. 2020 Jan 21;1(1):CD010885. doi: 10.1002/14651858.CD010885.pub5. Cochrane Database Syst Rev. 2020. PMID: 31961948 Free PMC article. - Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
van As JW, van den Berg H, van Dalen EC. van As JW, et al. Cochrane Database Syst Rev. 2018 Jul 5;7(7):CD010885. doi: 10.1002/14651858.CD010885.pub4. Cochrane Database Syst Rev. 2018. PMID: 29975402 Free PMC article. Updated. Review. - Study of the effects of chemotherapy on auditory function.
Dutta A, Venkatesh MD, Kashyap RC. Dutta A, et al. Indian J Otolaryngol Head Neck Surg. 2005 Jul;57(3):226-8. doi: 10.1007/BF03008019. Indian J Otolaryngol Head Neck Surg. 2005. PMID: 23120177 Free PMC article. - Impact of childhood cancer on return to normal schooling.
Larcombe IJ, Walker J, Charlton A, Meller S, Morris Jones P, Mott MG. Larcombe IJ, et al. BMJ. 1990 Jul 21;301(6744):169-71. doi: 10.1136/bmj.301.6744.169. BMJ. 1990. PMID: 2390606 Free PMC article. - Platinum-induced hearing loss after treatment for childhood cancer.
van As JW, van den Berg H, van Dalen EC. van As JW, et al. Cochrane Database Syst Rev. 2016 Aug 3;2016(8):CD010181. doi: 10.1002/14651858.CD010181.pub2. Cochrane Database Syst Rev. 2016. PMID: 27486906 Free PMC article. Review.